Sofia Hadzilia

Dr. Sofia Hadzilia


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Kassiani TheodorakiKassiani Theodoraki
Kassiani Theodoraki
SHSofia Hadzilia
Sofia Hadzilia
DVDimitrios Valsamidis
Dimitrios Valsamidis
KKKONSTANTINA KALOPITA
KONSTANTINA KALOPITA
ESEmmanouil Stamatakis
Emmanouil Stamatakis
Background and Goal of Study: Spinal anesthesia for cesarean section is frequently associated with a high incidence of hypotension, which may bring about untoward effects for both the mother and fetus. Recently, norepinephrine has emerged as a promising alternative in maintaining blood pressure in the obstetric setting. Fluid administration is another technique still widely used to prevent maternal hypotension. The optimal fluid strategy to prevent maternal hypotension has not been elucidated yet. It has been recently suggested that the main strategy in the prevention and management of hypotension should be the combination of vasoconstrictive medications and fluid administration. The aim of this randomized study was to compare the incidence of maternal hypotension in parturients receiving either colloid preload or crystalloid co-load in the setting of prophylactic norepinephrine infusion during elective cesarean section under combined spinal–epidural anesthesia. Materials and Methods: After ethics committee approval, 102 parturients with full-term singleton pregnancies were randomly allocated to either 6% hydroxyethyl starch 130/0.4 5 mL/kg before the onset of spinal anesthesia (colloid preload group) or Ringer’s lactate solution 10 mL/kg concurrent with the subarachnoid injection (crystalloid co-load group). In both groups, norepinephrine 4 μg/min starting simultaneously with the administration of the subarachnoid solution was also administered. The primary outcome of the study was the incidence of maternal hypotension, defined as systolic arterial pressure (SAP) <80% of baseline. The incidence of severe hypotension (SAP < 80 mmHg), total dose of vasoconstrictive agents administered, as well as the acid–base status and Apgar score of the neonate and any incidence of maternal side effects were also recorded. Results: Data analysis was performed on 100 parturients: 51 in the colloid preload group and 49 in the crystalloid co-load group. No significant differences were demonstrated between the colloid preload group and the crystalloid co-load group in the incidence of hypotension (13.7% vs. 16.3%, p = 0.933) or the incidence of severe hypotension (0% vs. 4%, p = 0.238). The median (range) ephedrine dose was 0 (0–15) mg in the colloid preload group and 0 (0–10) mg in the crystalloid co-load group (p = 0.807). The incidence of bradycardia, reactive hypertension, requirement for modification of vasopressor infusion, time to the first occurrence of hypotension, and maternal hemodynamics did not differ between the two groups. There were no significant differences in other maternal side effects or neonatal outcomes between groups. Conclusions: The incidence of hypotension with a norepinephrine preventive infusion is low and comparable with both colloid preload and crystalloid co-load. Both fluid-loading techniques are appropriate in women undergoing cesarean delivery. It appears that the optimal regimen for prevention of maternal hypotension is a combined strategy of a prophylactic vasopressor such as norepinephrine and fluids.


31 October 2005 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
ALA. Louizos
A. Louizos
SHSofia Hadzilia
Sofia Hadzilia
ESE. Samanta
E. Samanta
AKA. Krana
A. Krana
MSM. Skalistira
M. Skalistira
LGL. Georgiou
L. Georgiou

1 September 2005 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
SHSofia Hadzilia
Sofia Hadzilia
ALA. Louizos
A. Louizos
OKO. Kalathaki
O. Kalathaki
SKS. Kyriakoulakos
S. Kyriakoulakos
APA. Papadima
A. Papadima
LGL. Georgiou
L. Georgiou

31 October 2005 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
CKC. Kristolobeanou
C. Kristolobeanou
SHSofia Hadzilia
Sofia Hadzilia
ALA. Louizos
A. Louizos
AKA. Krana
A. Krana
IKI. Kouroukli
I. Kouroukli
LGL. Georgiou
L. Georgiou

31 October 2004 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
SHSofia Hadzilia
Sofia Hadzilia
SKS. Kyriakoulakos
S. Kyriakoulakos
MSM. Skalistira
M. Skalistira
CKC. Koraka
C. Koraka
APA. Papadima
A. Papadima
ALA. Louizos
A. Louizos